Proteomic analysis as a tool identify macrophage targets for anti-Leishmania chemotherapy

Menezes, Juliana Perrone Bezerra de; Almeida, Tais Fontoura de; Petersen, Antonio Luis de Oliveira Almeida; Guedes, Carlos Eduardo Sampaio; Mota, M. S. V.; Lima, José Geraldo Bomfim; Palma, Luana Carneiro; Buck, Gregory A.; Marchine, Fabricio; Krieger, Marco Aurélio; Probst, Christian M.; Veras, Patrícia Sampaio Tavares.
No convencional en Inglés | ARCA | ID: arc-39146

Documentos relacionados

  1. Serum proteome in acute myocardial infarction
  2. The anti-Leishmania potential of bioactive compounds derived from naphthoquinones and their possible applications. A systematic review of animal studies.
  3. Antileishmanial and Immunomodulatory Effect of Babassu-Loaded PLGA Microparticles: A Useful Drug Target to <i>Leishmania amazonensis</i> Infection.
  4. Anti-Leishmania IgA in urine samples from dogs with clinical leishmaniasis.
  5. One-year follow-up of anti-Leishmania antibody concentrations in serum and saliva from experimentally infected dogs.
  6. Evaluation of indirect immunofluorescence antibody test and enzyme-linked immunosorbent assay for the diagnosis of infection by Leishmania infantum in clinically normal and sick cats.
  7. The in vitro antileishmanial activity of essential oil from Aloysia gratissima and guaiol, its major sesquiterpene against Leishmania amazonensis.
  8. Anti-Leishmania activity of essential oil of Myracrodruon urundeuva (Engl.) Fr. All.: Composition, cytotoxity and possible mechanisms of action.
  9. MHC class II restricted innate-like double negative T cells contribute to optimal primary and secondary immunity to Leishmania major.
  10. Diagnostic usefulness of immunohistochemical evaluation of CD1a antigen and polyclonal anti-leishmania antibodies in cutaneous leishmaniasis.